.cls-1,.cls-3{fill:#083782;}.cls-2,.cls-3{fill-rule:evenodd;}.cls-2{fill:url(#linear-gradient);} We are an experienced team with diverse backgrounds working to make a difference for cancer patients. The people at Tempest have come together to discover and develop novel therapeutics to treat cancer – a challenging goal, but worth it. Although it’s nice to have, hope isn’t a strategy for success, so we seek colleagues across all functions who can hit the ground running and share our passion for patients, science, and drug development. We have established and plan to nurture a culture that is inclusive and embodies the company’s Guiding Principles. People of color and those who are part of underrepresented groups in the biotech industry are encouraged to apply for open positions. GUIDING PRINCIPLES The Tempest team believes in establishing a culture, as opposed to letting it happen. Consequently, we strive to adhere to our Guiding Principles, which provide the framework for a work environment that is constructive, productive and satisfying. JOIN OUR TEAM ASSOCIATE SCIENTIST / SR. RESEARCH ASSOCIATE CORPORATE COUNSEL RESEARCH ASSOCIATE SCIENTIST I/II SEC REPORTING MANAGER Tempest Therapeutics, Inc. is an Equal Opportunity Employer and all applicants will be considered for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. © 2021 Tempest Therapeutics, Inc. All rights reserved. Website Design: Hane Chow, Inc.

.cls-1,.cls-3{fill:#083782;}.cls-2,.cls-3{fill-rule:evenodd;}.cls-2{fill:url(#linear-gradient);} Contact Us Tempest Therapeutics 7000 Shoreline Court Suite 275 South San Francisco, CA 94080 General information: info@tempesttx.com JOIN the TEAM careers@tempesttx.com © 2021 Tempest Therapeutics, Inc. All rights reserved. Website Design: Hane Chow, Inc.

Skip to main navigation Home News & Events Stock Information Corporate Governance Financials & Filings Investor Resources Price Change TPST Data Provided by Refinitiv. Minimum 15 minutes delayed. Investor Relations Tempest Therapeutics is a clinical-stage biotechnology company developing first-in-class small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Site - View All Profile Learn More Site - Hero Menu Stock Info  News Releases  SEC Filings  FAQs  News Releases NOV 18 2021 Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab Read More NOV 12 2021 Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer Read More NOV 10 2021 Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights Read More Site - View All News View All Events NOV 22 2021 at 10:00 AM EST Piper Sandler 33rd Annual Virtual Healthcare Conference Read More NOV 18 2021 at 8:00 AM GMT Jefferies London Healthcare Conference Read More MAR 29 2021 at 8:30 AM EDT Tempest and Millendo Proposed Merger Investor Call Read More Site - View All Events View All © 2021 Tempest Therapeutics. All rights reserved.